Clinical Trials
2 trialsNCT03830411 2021-11-08
A Study of Sintilimab Compared With Docetaxel or Pemetrexed as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer After Failure With Platinum-Containing Chemotherapy
China Three Gorges University, Yichang, China
Phase 2 Unknown
NCT03863483 2021-11-08
A Study of Sintilimab or Placebo in Combination With Chemotherapy as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer With Wild-type EGFR After Failure With Platinum-Containing Chemotherapy.
China Three Gorges University, Yichang, China
Phase 2 Unknown